Search results
Results from the WOW.Com Content Network
Life Technologies Corporation was a biotech company founded in November 2008 through a US $6.7 billion merger of Invitrogen Corporation and Applied Biosystems Inc. The joint sales of the combined companies were about $3.5 billion; they had about 9,500 employees and owned more than 3,600 licenses and patents.
The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. [30] In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. ASI designs manufactures, and delivers technologies used in bioprocessing. [31]
The business scope expanded significantly when it acquired the rival biotechnology and cell culture company Life Technologies in 2000; Life had been formed in 1983 when GIBCO (Grand Island Biological Company) which had been founded around 1960 in New York, merged with a reagent company called Bethesda Research Laboratories. The company ...
Life Technologies , a giant in the gene sequencing space, had a healthy start to 2013. This stock popped in January on speculation that the company was exploring the possibility of a buyout.
On April 27, 1999, [18] the shareholders of Perkin-Elmer Corporation approved the reorganization of Perkin-Elmer into PE Corporation, a pure-play life science company. [20] Each share of the Perkin-Elmer stock (PKN) was to be exchanged for one share and for + 1 ⁄ 2 of a share respectively of the two new common share tracking stocks for the ...
Navigenics was co-founded in 2006 by David Agus, M.D., a prostate cancer specialist who is a professor of medicine at the University of Southern California and director of the USC Center for Applied Molecular Medicine and the USC Westside Prostate Cancer Center in Los Angeles, and Dietrich Stephan, Ph.D., member of the board of directors of the Personalized Medicine Coalition, current CEO of ...
Life Technologies Corp. v. Promega Corp., 580 U.S. ___ (2017), was a case in which the United States Supreme Court clarified the application of the Patent Act of 1952 to the sale of components of patented inventions in foreign markets. [1]
Caliper Life Sciences was founded in 1995 by Larry Bock and Drs. Michael Knapp, Michael Ramsey and Andreas Manz. as Caliper Technologies, with a focus on microfluidics technology. In 2003, the firm acquired Zymark, a company with a focus in laboratory automation and robotics, and was renamed Caliper Life Sciences.